FIELD: medicine.
SUBSTANCE: what is described is a group of genetic make-ups expressing RNA-sequences and genes coding proteins, exhibiting anti-viral activity with respect to human immunodeficiency virus. The make-ups including one or more genetic anti-viral agents show strong antiviral properties.
EFFECT: applicability in medicine.
25 cl, 12 dwg, 6 tbl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVING GENETIC CONSTRUCTS FOR PROVIDING HIGH EFFICACY OF ANTI-HIV THERAPY | 2013 |
|
RU2533817C1 |
| METHOD OF DETERMINING LEVEL OF CHIMERIC GENE Trim5a EXPRESSION | 2015 |
|
RU2592675C1 |
| GENETIC CONSTRUCTS AND THEIR MIXTURES FOR ANTI-HIV THERAPY | 2017 |
|
RU2666991C1 |
| DOUBLE VECTOR FOR SUPPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS | 2010 |
|
RU2562868C2 |
| AUXILIARY PLASMID LENTIVIRAL EXPRESSION VECTOR FOR OBTAINING HIGH TITERS OF Vpx-CONTAINING LENTIVIRAL PARTICLES, WHICH PROVIDES EFFECTIVE INFECTION OF HUMAN MONOCYTES AND DENDRITIC CELLS | 2017 |
|
RU2697781C2 |
| BIOPRODUCTION OF LENTIVIRAL VECTORS | 2016 |
|
RU2729385C2 |
| MICROVESICLE AND METHOD FOR ITS PREPARATION | 2014 |
|
RU2693088C2 |
| RECOMBINANT LENTIVIRAL VECTOR, HOST CELL TRANSDUCED WITH LENTIVIRAL VECTOR, METHODS FOR TRANSDUCTION AND USES THEREOF | 2002 |
|
RU2305708C2 |
| REPORTER SYSTEM BASED ON LENTIVIRUS REPORTER STRUCTURES FOR STUDY OF PROTEIN-PROTEIN INTERACTIONS | 2015 |
|
RU2639539C2 |
| ASLV-BASED VECTOR SYSTEM | 2010 |
|
RU2566563C2 |
